
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $15.1M | -- | -- | -- | -- |
08/08/2025 | Q2 | $10.6M | -- | -- | -$0.01 | -- |
05/13/2025 | Q1 | $10.5M | $10.5M | -$0.02 | -$0.01 | -$0.01 |
03/28/2025 | Q4 | $12.4M | $14.6M | $0.01 | -$0.02 | $0.03 |
11/12/2024 | Q3 | $12.6M | $13.3M | -$0.03 | -$0.04 | $0.01 |
08/08/2024 | Q2 | $9.9M | $12.3M | -$0.05 | -$0.03 | -$0.02 |
05/14/2024 | Q1 | $9M | $10M | -$0.27 | -$0.04 | -$0.23 |
03/14/2024 | Q4 | $9M | $8.6M | -$0.06 | -$0.02 | -$0.04 |
11/09/2023 | Q3 | -- | -- | -$0.02 | -$0.04 | $0.02 |
08/10/2023 | Q2 | -- | -- | -$0.07 | -$0.02 | -$0.05 |
05/11/2023 | Q1 | -- | -- | -$0.03 | -$0.03 | -- |
03/14/2023 | Q4 | -- | -- | -$0.07 | -$0.04 | -$0.03 |
11/01/2022 | Q3 | -- | -- | -$0.07 | -$0.04 | -$0.03 |
08/02/2022 | Q2 | -- | -- | -$0.06 | -$0.03 | -$0.03 |
05/03/2022 | Q1 | -- | -- | -$0.02 | -$0.03 | $0.01 |
03/08/2022 | Q4 | -- | -- | -$0.04 | -$0.03 | -$0.01 |
11/02/2021 | Q3 | -- | -- | -$0.02 | -$0.04 | $0.02 |
08/03/2021 | Q2 | -- | -- | -$0.04 | -$0.02 | -$0.02 |
05/04/2021 | Q1 | -- | -- | -$0.05 | -$0.02 | -$0.03 |
03/02/2021 | Q4 | -- | -- | $0.02 | -$0.01 | $0.03 |
11/03/2020 | Q3 | -- | -- | -$0.01 | -$0.02 | $0.01 |
08/04/2020 | Q2 | -- | -- | -$0.01 | -$0.05 | $0.04 |
05/05/2020 | Q1 | -- | -- | -$0.04 | -$0.05 | $0.01 |
03/10/2020 | Q4 | -- | -- | -$0.09 | -$0.05 | -$0.05 |
11/07/2019 | Q3 | -- | -- | -$0.08 | -$0.06 | -$0.03 |
08/08/2019 | Q2 | -- | -- | -$0.05 | -$0.09 | $0.04 |
05/07/2019 | Q1 | -- | -- | -$0.14 | -$0.09 | -$0.05 |
03/12/2019 | Q4 | -- | -- | -$0.14 | -$0.10 | -$0.05 |
11/08/2018 | Q3 | -- | -- | -$0.12 | -$0.10 | -$0.02 |
08/06/2018 | Q2 | -- | -- | -$0.11 | -$0.35 | $0.24 |
05/08/2018 | Q1 | -- | -- | -$0.05 | -$0.08 | $0.03 |
03/08/2018 | Q4 | -- | -- | -$0.05 | -$0.05 | -$0.00 |
11/07/2017 | Q3 | -- | -- | -$0.10 | -$0.07 | -$0.03 |
08/08/2017 | Q2 | -- | -- | -$0.09 | -$0.08 | -$0.01 |
05/09/2017 | Q1 | -- | -- | -$0.11 | -$0.10 | -$0.01 |
03/13/2017 | Q4 | -- | -- | -- | -- | -- |
10/27/2016 | Q3 | -- | -- | -- | -- | -- |
08/02/2016 | Q2 | -- | -- | -- | -- | -- |
05/04/2016 | Q1 | -- | -- | -- | -- | -- |
03/03/2016 | Q4 | -- | -- | -- | -- | -- |
11/03/2015 | Q3 | -- | -- | -- | -- | -- |
Kopin reported $10.5M worth of top line sales in its most recent quarter.
Kopin announced earnings per share of -$0.02 which represents a miss of analyst forecast a -$0.01 per share.
Kopin reported $2.9M that represents $0.02 per share over the last quarter.
Kopin's earnings are forecast to decrease from -$0.33 per share to -$0.20 per share next year representing a decrease of -96.97%.
Kopin's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.